Tang-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "KNSA",
  "NUVL",
  "EWTX",
  "CNTA",
  "INSM",
  "RVMD",
  "ENTA",
  "JAZZ",
  "ACAD",
  "ALXO",
  "BABA",
  "TGTX",
  "ALL",
  "PTCT",
  "AXP",
  "ANIP",
  "ABCL",
  "ADMA",
  "AAT",
  "GLPG",
  "GMAB",
  "DVAX",
  "NVAX",
  "MGX",
  "SWTX",
  "TCRX",
  "AVDL",
  "AUPH",
  "RCKT",
  "ARVN",
  "ANAB",
  "ALT",
  "ATXS",
  "SLRN",
  "TBPH",
  "RLAY",
  "MIRM",
  "THRD",
  "NUVB",
  "LENZ",
  "LQDA",
  "ACET",
  "MNMD",
  "STOK",
  "TECX",
  "MLYS",
  "REPL",
  "PHAT",
  "SNDX",
  "NMRA",
  "KROS",
  "LEGN",
  "ALGS",
  "AFMD",
  "ALLK",
  "ATHA",
  "AMLX",
  "JANX",
  "APLT",
  "ATRA",
  "BIOA",
  "BCAB",
  "HD",
  "BLUE",
  "BOLT",
  "AZN",
  "MCD",
  "EPIX",
  "SYRE",
  "APGE",
  "FATE",
  "TARS",
  "IVVD",
  "NBIX",
  "META",
  "KALV",
  "MGNX",
  "NXTC",
  "OABI",
  "NKTX",
  "OTLK",
  "OKUR",
  "QNCX",
  "PYXS",
  "PBYI",
  "SEER",
  "MCRB",
  "LAB",
  "STRO",
  "IONS",
  "IOVA",
  "CYBN",
  "BLCO",
  "ATYR",
  "MSFT",
  "TMUS",
  "GE",
  "HRTX",
  "HRL",
  "IBRX",
  "ZYME",
  "PAYX",
  "PYPL",
  "UNH",
  "NVDA",
  "HPE",
  "INTC",
  "PFE",
  "PG",
  "VZ",
  "REGN",
  "SHW",
  "TXN",
  "UAL",
  "DTIL",
  null,
  "MRNA",
  "LXRX",
  "PLRX",
  "SLNO",
  "PASG",
  "RVPH",
  "ULTA",
  "SNY",
  "GSK",
  "GRAL",
  "ARE",
  "F",
  null,
  "CMPS",
  "ELEV",
  "ERAS",
  "EOLS",
  "FTRE",
  "IMCR",
  "HRMY",
  "DSGN",
  "HLVX",
  "ITOS",
  "KLRS",
  "DERM",
  "KRON",
  "KURA",
  "KOD",
  "IDXX",
  "KZR",
  "AMZN",
  "VNDA",
  "VTYX",
  "VSTM",
  "VTRS",
  "V",
  "VKTX",
  "VIR",
  "VRDN",
  "WMT",
  "WHR",
  "ZNTL",
  "ELAN",
  "OPRX",
  "VERA",
  "BIIB",
  "BHVN",
  null,
  "TDOC",
  "SEE",
  "LNTH",
  "GEV",
  "PCVX",
  "FDX",
  "AVIR",
  "BRK-B",
  "BEAM",
  null,
  "BDTX",
  "BCRX",
  "BNTX",
  "BA",
  "CCCC",
  "CDNA",
  "CAPR",
  "CRGX",
  "SAVA",
  "IPSC",
  "CVX",
  "CLX",
  "KO",
  "CHRS",
  "CMPX",
  "CRBP",
  "CRSP",
  "CGEM",
  "CTMX",
  "CYTK",
  "DNTH",
  "NKE",
  "DIS",
  "XOM",
  "JNJ",
  "NFLX",
  "JPM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 202
Total Value: 1807581363
Accession Number: 0001214659-25-007882
Form Type: 13F-HR
CIK: tang-capital-management
Manager Name: Tang-Capital-Management

Data Enrichment

98% identified

198 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

202 positions • $1.8B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 11

Sort by:

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

Shares:2.5M

Value:$126.1M

% of Portfolio:7.0% ($126.1M/$1.8B)

GALAPAGOS NV

GLPG|36315X101

Shares:4.0M

Value:$99.5M

% of Portfolio:5.5% ($99.5M/$1.8B)

Aurinia Pharmaceuticals Inc.

AUPH|05156V102

Shares:10.0M

Value:$80.6M

% of Portfolio:4.5% ($80.6M/$1.8B)

DYNAVAX TECHNOLOGIES CORP

DVAX|268158201

Shares:5.8M

Value:$74.6M

% of Portfolio:4.1% ($74.6M/$1.8B)

Evolus, Inc.

EOLS|30052C107

Shares:5.0M

Value:$60.1M

% of Portfolio:3.3% ($60.1M/$1.8B)

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:4.9M

Value:$57.0M

% of Portfolio:3.2% ($57.0M/$1.8B)

Immunocore Holdings plc

IMCR|45258D105

Shares:1.9M

Value:$56.8M

% of Portfolio:3.1% ($56.8M/$1.8B)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:1.2M

Value:$55.7M

% of Portfolio:3.1% ($55.7M/$1.8B)

PTC THERAPEUTICS, INC.

PTCT|69366J200

Shares:1.0M

Value:$51.0M

% of Portfolio:2.8% ($51.0M/$1.8B)

Kiniksa Pharmaceuticals International, plc

KNSA|G52694109

Shares:2.1M

Value:$47.1M

% of Portfolio:2.6% ($47.1M/$1.8B)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:2.8M

Value:$37.6M

% of Portfolio:2.1% ($37.6M/$1.8B)

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:2.0M

Value:$33.1M

% of Portfolio:1.8% ($33.1M/$1.8B)

46116X101

Shares:220.0K

Value:$29.0M

% of Portfolio:1.6% ($29.0M/$1.8B)

ANAPTYSBIO, INC

ANAB|032724106

Shares:1.5M

Value:$28.7M

% of Portfolio:1.6% ($28.7M/$1.8B)

Replimune Group, Inc.

REPL|76029N106

Shares:2.9M

Value:$28.3M

% of Portfolio:1.6% ($28.3M/$1.8B)

Legend Biotech Corp

LEGN|52490G102

Shares:830.0K

Value:$28.2M

% of Portfolio:1.6% ($28.2M/$1.8B)

ACADIA PHARMACEUTICALS INC

ACAD|004225108

Shares:1.5M

Value:$24.9M

% of Portfolio:1.4% ($24.9M/$1.8B)

BioNTech SE

BNTX|09075V102

Shares:270.0K

Value:$24.6M

% of Portfolio:1.4% ($24.6M/$1.8B)

ACELYRIN, Inc.

SLRN|00445A100

Shares:9.8M

Value:$24.3M

% of Portfolio:1.3% ($24.3M/$1.8B)

Jazz Pharmaceuticals plc

JAZZ|G50871105

Shares:190.0K

Value:$23.6M

% of Portfolio:1.3% ($23.6M/$1.8B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	2.5M	QoQ +8.86% (+200.0K) YoY +8.86% (+200.0K)	All Managers (Combined)	$126.1M	7.0% ($126.1M/$1.8B)	QoQ +1.00% (+$1.3M) YoY +53.85% (+$44.1M)
GALAPAGOS NV(GLPGcusip36315X101)	4.0M	QoQ +83.31% (+1.8M) YoY NEW(+4.0M)	All Managers (Combined)	$99.5M	5.5% ($99.5M/$1.8B)	QoQ +67.44% (+$40.1M) YoY NEW(+$99.5M)
Aurinia Pharmaceuticals Inc.(AUPHcusip05156V102)	10.0M	QoQ +18.98% (+1.6M) YoY +389.24% (+8.0M)	All Managers (Combined)	$80.6M	4.5% ($80.6M/$1.8B)	QoQ +6.52% (+$4.9M) YoY +685.13% (+$70.4M)
DYNAVAX TECHNOLOGIES CORP(DVAXcusip268158201)	5.8M	QoQ +210.81% (+3.9M) YoY NEW(+5.8M)	All Managers (Combined)	$74.6M	4.1% ($74.6M/$1.8B)	QoQ +215.67% (+$51.0M) YoY NEW(+$74.6M)
Evolus, Inc.(EOLScusip30052C107)	5.0M	QoQ 0.00% (+0) YoY +20.49% (+850.0K)	All Managers (Combined)	$60.1M	3.3% ($60.1M/$1.8B)	QoQ +8.96% (+$4.9M) YoY +3.53% (+$2.1M)
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	4.9M	QoQ +0.97% (+48.0K) YoY +19.79% (+816.5K)	All Managers (Combined)	$57.0M	3.2% ($57.0M/$1.8B)	QoQ +37.58% (+$15.6M) YoY +16.55% (+$8.1M)
Immunocore Holdings plc(IMCRcusip45258D105)	1.9M	QoQ +23.14% (+360.1K) YoY +372.31% (+1.5M)	All Managers (Combined)	$56.8M	3.1% ($56.8M/$1.8B)	QoQ +23.85% (+$10.9M) YoY +115.59% (+$30.5M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	1.2M	QoQ 0.00% (+0) YoY +4.21% (+50.0K)	All Managers (Combined)	$55.7M	3.1% ($55.7M/$1.8B)	QoQ +8.94% (+$4.6M) YoY +86.89% (+$25.9M)
PTC THERAPEUTICS, INC.(PTCTcusip69366J200)	1.0M	QoQ +42.85% (+300.0K) YoY +42.85% (+300.0K)	All Managers (Combined)	$51.0M	2.8% ($51.0M/$1.8B)	QoQ +61.27% (+$19.4M) YoY +150.25% (+$30.6M)
Kiniksa Pharmaceuticals International, plc(KNSAcusipG52694109)	2.1M	QoQ +237.02% (+1.5M) YoY NEW(+2.1M)	All Managers (Combined)	$47.1M	2.6% ($47.1M/$1.8B)	QoQ +278.43% (+$34.6M) YoY NEW(+$47.1M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	2.8M	QoQ +12.03% (-300.0K) YoY +303.06% (+2.1M)	All Managers (Combined)	$37.6M	2.1% ($37.6M/$1.8B)	QoQ -21.21% (-$10.1M) YoY +210.29% (+$25.5M)
Spyre Therapeutics, Inc.(SYREcusip00773J202)	2.0M	QoQ NEW(+2.0M) YoY NEW(+2.0M)	All Managers (Combined)	$33.1M	1.8% ($33.1M/$1.8B)	QoQ NEW(+$33.1M) YoY NEW(+$33.1M)
(cusip46116X101)✕	220.0K	QoQ -26.66% (-80.0K) YoY +46.66% (+70.0K)	All Managers (Combined)	$29.0M	1.6% ($29.0M/$1.8B)	QoQ +15.83% (-$4.0M) YoY +179.59% (+$18.6M)
ANAPTYSBIO, INC(ANABcusip032724106)	1.5M	QoQ +16.10% (+214.3K) YoY +16.10% (-214.3K)	All Managers (Combined)	$28.7M	1.6% ($28.7M/$1.8B)	QoQ +63.01% (+$11.1M) YoY -4.16% (-$1.2M)
Replimune Group, Inc.(REPLcusip76029N106)	2.9M	QoQ +7.40% (-200.0K) YoY NEW(+2.9M)	All Managers (Combined)	$28.3M	1.6% ($28.3M/$1.8B)	QoQ -13.52% (-$4.4M) YoY NEW(+$28.3M)
Legend Biotech Corp(LEGNcusip52490G102)	830.0K	QoQ +84.44% (+380.0K) YoY NEW(+830.0K)	All Managers (Combined)	$28.2M	1.6% ($28.2M/$1.8B)	QoQ +92.32% (+$13.5M) YoY NEW(+$28.2M)
ACADIA PHARMACEUTICALS INC(ACADcusip004225108)	1.5M	QoQ 0.00% (-0) YoY +189.07% (+981.1K)	All Managers (Combined)	$24.9M	1.4% ($24.9M/$1.8B)	QoQ -9.48% (-$2.6M) YoY +159.68% (+$15.3M)
BioNTech SE(BNTXcusip09075V102)	270.0K	QoQ 0.00% (-0) YoY NEW(+270.0K)	All Managers (Combined)	$24.6M	1.4% ($24.6M/$1.8B)	QoQ -20.08% (-$6.2M) YoY NEW(+$24.6M)
ACELYRIN, Inc.(SLRNcusip00445A100)	9.8M	QoQ NEW(+9.8M) YoY NEW(+9.8M)	All Managers (Combined)	$24.3M	1.3% ($24.3M/$1.8B)	QoQ NEW(+$24.3M) YoY NEW(+$24.3M)
Jazz Pharmaceuticals plc(JAZZcusipG50871105)	190.0K	QoQ +35.71% (+50.0K) YoY NEW(+190.0K)	All Managers (Combined)	$23.6M	1.3% ($23.6M/$1.8B)	QoQ +36.81% (+$6.3M) YoY NEW(+$23.6M)